Ambroxol hydrochloride
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Flavamed is a mucolytic agent used in respiratory tract diseases. Flavamed is indicated for use in adults, adolescents, and children over 6 years of age. Flavamed is used in acute and chronic lung and bronchial diseases, characterized by the production of thick mucus. Thanks to the use of Flavamed, thick mucus becomes more watery and can be coughed up more easily.
Before starting to take Flavamed, the patient should discuss it with their doctor or pharmacist,
There have been reports of severe skin reactions associated with the use of ambroxol. If a rash occurs (including changes in the mucous membranes, e.g. in the mouth, throat, nose, eyes, genitals), the patient should stop taking Flavamed and contact their doctor immediately.
Flavamed can only be used in children over 6 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Ambroxol/cough suppressants
When taking Flavamed with medicines that suppress the cough reflex (cough suppressants), there may be a (dangerous) accumulation of bronchial secretions due to a weakened cough reflex in patients with underlying respiratory diseases characterized by excessive mucus production, such as cystic fibrosis or bronchiectasis.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
During pregnancy and breastfeeding, Flavamed can only be used if clearly prescribed by a doctor! The use of Flavamed is not recommended, especially during the first trimester of pregnancy.
It has been observed that the active substance contained in Flavamed passes into breast milk. Flavamed is not recommended during breastfeeding.
Animal studies have not shown any harmful effects of ambroxol on fertility.
There is no evidence of an effect on the ability to drive and use machines. No studies have been conducted on the effect on the ability to drive and use machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The following information applies if the doctor has not prescribed a different dosage of Flavamed.
The patient should follow the instructions for taking the medicine, otherwise Flavamed will not work properly!
Age | Single dose | Maximum daily dose |
Children aged 6 to 12 years | ½ tablet 2 to 3 times a day (equivalent to 15 mg of ambroxol hydrochloride 2-3 times a day). | 1½ tablets (equivalent to 45 mg of ambroxol hydrochloride). |
Adults and adolescents over 12 years of age | For the first 2-3 days, 1 tablet 3 times a day (equivalent to 30 mg of ambroxol hydrochloride 3 times a day); then 1 tablet twice a day (equivalent to 30 mg of ambroxol hydrochloride twice a day). | 3 tablets (equivalent to 90 mg of ambroxol hydrochloride). |
Note:
In adults, the daily dose can be increased to 2 tablets twice a day.
For oral use. Flavamed is best taken whole after a meal, with a sufficient amount of liquid (e.g. water, tea, or fruit juice).
The tablet can be divided into equal doses.
Without consulting a doctor, Flavamed should not be taken for more than 4-5 days.
If after 4-5 days the symptoms do not decrease or even worsen, the patient should contact their doctor immediately!
If the patient feels that the effect of Flavamed is too strong or too weak, they should consult their doctor or pharmacist.
So far, no specific symptoms of overdose have been reported in humans. Based on reports of accidental overdose and/or incorrect dosing, the observed symptoms are consistent with the known side effects of ambroxol hydrochloride at recommended doses, and symptomatic treatment may be necessary. The patient should contact their doctor.
In case of a missed dose or taking a smaller dose of the medicine, the patient should take the next prescribed dose at the usual time.
The patient should not take a double dose to make up for the missed dose.
If the patient has any further doubts about taking the medicine, they should consult their doctor or pharmacist.
Like all medicines, Flavamed can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1000 people) :
Unknown (frequency cannot be estimated from the available data):
If one or more of the above side effects occur, the patient should stop taking Flavamed immediately.
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist, or nurse.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Aleje Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the blister pack and carton after EXP. The expiry date refers to the last day of the month.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Flavamed is ambroxol hydrochloride.
One tablet contains 30 mg of ambroxol hydrochloride.
The other ingredients are: lactose monohydrate, corn starch, cellulose (powder), croscarmellose sodium, povidone K 30, magnesium stearate.
White, round tablets, flat on both sides, with beveled edges and a dividing line on one side.
Flavamed is available in packs containing: 10, 20, and 50 tablets.
Not all pack sizes may be marketed.
Berlin-Chemie AG
Glienicker Weg 125
12489 Berlin, Germany
To obtain more detailed information about this medicine, the patient should contact the local representative of the marketing authorization holder:
Berlin-Chemie/Menarini Polska Sp. z o.o.
Phone: +48 22 566 21 00
Fax: +48 22 566 21 01
Bulgaria:
Flavamed Cough Tablets
Estonia:
Flavamed 30 mg
Finland:
Flavamed 30 mg Tablets
Germany: Flavamed Hustentabletten
Latvia:
Flavamed Cough Tablets
Lithuania:
Flavamed Cough Tablets
Poland:
Flavamed
Slovak Republic:
Flavamed Cough Tablets
Slovenia:
Flavamed 30 mg Tablets
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.